• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Studies on expression and regulation of cytokine receptors on fibroblasts in radiation pneumonitis

Research Project

Project/Area Number 10670546
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Respiratory organ internal medicine
Research InstitutionThe University of Tokushima

Principal Investigator

TANI Kengi  The University of Tokushima, School of Medicine, Assistant Professor., 医学部・附属病院, 講師 (70207166)

Co-Investigator(Kenkyū-buntansha) OHGUSHI Fumitaka  The University of Tokushima, School of Medicine, Associate Professor., 医学部, 助教授 (80201375)
Project Period (FY) 1998 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥3,300,000 (Direct Cost: ¥3,300,000)
Fiscal Year 2000: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 1999: ¥700,000 (Direct Cost: ¥700,000)
Fiscal Year 1998: ¥2,100,000 (Direct Cost: ¥2,100,000)
Keywordsradiation pneumonitis / cytokine / cytokine receptor / fibroblast / PDGF / interstitial pneumonia / 放射線肺線維症
Research Abstract

Radiation therapy widely used for treating of thoracic malignancies often induces damage to normal lung tissue, esulting in radiation pneumonitis and pulmonary fibrosis. Pathologically, radiation pneumonitis is characterized by interstitial edema, infiltration of interstitial and alveolar inflammatory cells, increased Type II pneumocytes, fibrotic reaction by increased interstitial collagen deposition, thickening of vascular walls.
To clarify the role of thrombin in the pathogenesis of radiation-induced pneumonitis, we measured the thrombin activity and fibroblast growth-inducing activity in bronchoalveolar lavage fluid (BALF) obtained from irradiated rat lungs. Bronchoalveolar lavage fluid was collected at 1, 2, 4, 8 and 18 weeks after the irradiation. Higher fibroblast growth-inducing activity was detected in the BALF from irradiated rats at 4 and 18 weeks than from unirradiated rats. Pretreatment of BALF from irradiated rats at 4 weeks with thrombin inhibitors, antithrombin III and a … More rgatroban, significantly inhibited the fibroblast growth-inducing activity as well as the thrombin activity. On the other hand, these thrombin inhibitors did not inhibit fibroblast growth-inducing activity in BALF from irradiated rats at 18 weeks. Purified rat thrombin induced proliferation of fibroblasts from irradiated rats similar to those from unirradiated rats. These findings suggest that thrombin may play an important role as a fibroblast growth-inducing factor during early stages of radiation pneumonitis.
CD13/aminopeptidase N is a cell surface glycoprotein widely distributed in a variety of mammalian cells. CD13/aminopeptidase N has chemotactic activity for T lymphocytes, We examined the role of CD13/aminopeptidase N on lymphocytic alveolitis in radiation-induced lung injury in a rat model. Significantly increased aminopeptidase activity was detected in BALF obtained from irradiated rats at 4 weeks after irradiation compared with the activity in unirradiated rats. Significantly higher aminopeptidase activity was detected on alveolar macrophages (AM) from irradiated rats at 2 and 4 weeks than from unirradiated rats. Western blot analysis showed increased expression of CD13/aminopeptidase N protein in AM from irradiated rats at 4 weeks. Chemotactic activity for normal rat lymphocytes was detected in the BALF from irradiated rats at 4 weeks, and approximately sixty percent of the activity was inhibited by pretreatment of BALF with bestatin, a specific aminopeptidase inhibitor. This study suggests that CD13/aminopeptidase N may be important as a lymphocyte chemoattractant in lymphocyte-mediated alveolitis in experimental radiation-induced lung injury. Less

Report

(4 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • 1998 Annual Research Report
  • Research Products

    (12 results)

All Other

All Publications (12 results)

  • [Publications] Nishimura,N et al.: "Down-regulation by a new antiinflammatory compound, FR167653, of differentiation.…"Int.J.Immunopharmacol.. 22. 501-514 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Tani,K. et al.: "Defensins act as potent adjuvants that promote cellular and humoral…"Int.Immunol.. 12. 691-700 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Maniwa,K. et al.: "Increased incidence of autoantibodies to inferleukin-1a in rheumatoid arteritis…"Respirology. 5. 315-320 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Nishimura, N., Nishioka, Y., Shinohara, T., Tani, K., Sone, S.: "Down-regulation by a new anti-inflammatory compound, FR167653, of differentiation and maturation of human monocytes and bone marrow CD34+ cells to dendritic cells."Int.J.Immunopharmacol.. 22. 501-514 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Tani, K., Murphy, W.J., Chertov, O., Salcedo, R., Koh, C.Y., Utsunomiya, I., Funakoshi, S., Asai, O., Herrmann, S.H., Wang, J.M., Kwak, L.W., Oppenheim, J.J.: "Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens."Int.Immunol. 12. 691-700 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Maniwa, K., Ogushi, F., Tani, K., Ohmoto, Y., Muraguchi, M., Sone, S.: "Increased incidence of autoantibodies to interleukin-1a in rheumatoid arthritis with interstitial lung disease."Respirology. 5. 315-320 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Nishimura,N, et al.: "Down-regulation by a new anti-inflammatory compound, FR167653, of differentiation."Int.J.Immunopharmacol.. 22. 501-514 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Tani,K, et al.: "Defensins act as potent adjuvants that promote cellular and humoral"Int.Immunol.. 12. 691-700 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Maniwa,K, et al.: "Increased incidence of autoantibodies to interleukin-la in rheumatoid arthritis."Respirology. 5. 315-320 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Ichikawa,W.,et al.: "Characterization of immunoglobulin binding factor in sputum from patients with chronic airway diseases"Respirology. 4. 375-381 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Tani,K.,et al.: "CD131 aminoperptidase N: A novel chemotlractant for T lymphocytes in pulmonary sarcoidosis"Am J Respir Crit Care Med. (in press). (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] Tani,K.,et al.: "Chymase is a potent chemoatlractant for human monocytes and neutrophils"J Leukoc Biol. (in press). (2000)

    • Related Report
      1999 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi